-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Rallybio Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2024.
- Rallybio Corp Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $1.44 M, a 10.9% decline year-over-year.
- Rallybio Corp Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $6.23 M, a 67.8% increase year-over-year.
- Rallybio Corp annual Nonoperating Income (Expense) for 2023 was $6.41 M, a 178% increase from 2022.
- Rallybio Corp annual Nonoperating Income (Expense) for 2022 was $2.31 M, a 1546% increase from 2021.
- Rallybio Corp annual Nonoperating Income (Expense) for 2021 was $140 K, a 61.4% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)